Skip Ribbon Commands
Skip to main content
Sign In
​​ ​ ​​​​​
Biomedical Advanced Research and Development Authority (BARDA) Capabilities
The Biomedical Advanced Research and Development Authority (BARDA) improves national preparedness for chemical, biological, radiological, and nuclear (CBRN) accidents and attacks, pandemic influenza, and emerging infectious diseases by supporting the development and acquisition of medical countermeasures (MCM) against these threats. BARDA programs and initiatives that provide support to national incident response and recovery preparedness include: Chemical, Biological, Radiological and Nuclear Medical Countermeasures, Pandemic Influenza Medical Countermeasures, Analytical Decision Support, the Fill Finish Manufacturing Network, Non-Clinical Studies Network, Clinical Studies Network, and Centers for Innovation in Advanced Development and Manufacturing.
Food and Drug Administration (FDA) Response Resources
During a disaster or other crisis situation, the US Food and Drug Administration (FDA) may assist other federal, state, local, and/or tribal authorities in response/recovery activities which deal with FDA regulated products such as drugs, medical devices, biologics, human food and animal feed, and cosmetics. This assistance may take a variety of forms, such as assistance in inspections of establishments which produce or distribute FDA regulated products, providing subject matter expertise on the use, storage, or quality of these products, or assistance in sample collections of these products. FDA response/recovery activities may be initiated through FDA’s inherent regulatory authority over these products, or through mission assignments as part of a larger federal response.